Abeona Therapeutics® Announces Date of Third Quarter Financial Results and Upcoming Investor Conference Participation

Core Viewpoint - Abeona Therapeutics Inc. is set to discuss its third quarter 2025 financial results and corporate progress in an upcoming conference call on November 12, 2025 [1] Group 1: Conference Call Details - The conference call will take place at 8:30 a.m. ET and will be accessible via phone and webcast [1][2] - Participants can join the call by dialing 877-545-0523 (U.S. toll-free) or 973-528-0016 (international) with Entry Code: 922481 [2] - A live webcast and archived replay will be available on the company's website for 30 days following the call [2] Group 2: Upcoming Investor Conference - Abeona management will participate in a fireside chat at the Stifel 2025 Healthcare Conference on November 13, 2025, at 1:20 p.m. ET [3] - The fireside chat will also be available via a live webcast and archived for 30 days [3] Group 3: Company Overview - Abeona Therapeutics is a commercial-stage biopharmaceutical company focused on developing cell and gene therapies for serious diseases [4] - The company's ZEVASKYN® is the first autologous cell-based gene therapy for treating wounds in patients with recessive dystrophic epidermolysis bullosa (RDEB) [4] - Abeona operates a fully integrated cGMP manufacturing facility in Cleveland, Ohio, which is responsible for ZEVASKYN's commercial production [4] - The company is also developing AAV-based gene therapies for ophthalmic diseases with high unmet medical needs [4]